Photocure ASA announced the start of its Cysview® sales, marketing and distribution operations in the Canadian market. In August 2021Photocure had reached an agreement with BioSyent Pharma Inc. to reacquire the marketing and distribution rights to Cysviewin Canada, effective on January 1st, 2022. The reacquisition of marketing and distribution rights enables Photocure's direct management of the Cysview brand in Canada and consolidates the territory into Photocure's existing U.S. business to form its North America sales segment.

Following the Marketing Authorization transfer expected this month, Photocure assumes all rights and obligations related to Cysview in Canada.